The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A national survey of current scenario and future perspectives of cancer research in Brazil.
 
Heloisa Resende
Consulting or Advisory Role - Libbs
Speakers' Bureau - Libbs
Research Funding - Libbs
Travel, Accommodations, Expenses - pfizer
 
Taiane Francieli Rebelatto
No Relationships to Disclose
 
Gustavo Werutsky
Honoraria - AstraZeneca/MedImmune; Libbs; Merck; Pfizer
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb Brazil (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis; Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech
 
Gustavo Cartaxo de Lima Gössling
Research Funding - AstraZeneca/Merck (Inst); Janssen Oncology (Inst)
 
Vinícius Aguiar
No Relationships to Disclose
 
Guilherme Lopes
No Relationships to Disclose
 
Biazi Assis
No Relationships to Disclose
 
Lilian Martins Arruda
No Relationships to Disclose
 
Carlos H. Barrios
Stock and Other Ownership Interests - MedSIR; Tummi
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Libbs; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech; United Medical
Research Funding - AB Science (Inst); Abbvie (Inst); Abraxis BioScience (Inst); Amgen (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clinica Atlantis (Inst); Covance (Inst); Daiichi Sankyo (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); ImClone Systems (Inst); INC Research (Inst); inVentiv Health (Inst); Janssen (Inst); LEO Pharma (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merrimack (Inst); Millennium (Inst); Mylan (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Polyphor (Inst); Roche/Genentech (Inst); Sanofi (Inst); Shanghai Henlius Biotech (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS Brazil; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech